Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder Carcinoma

Table 4

The pathway enriched for the 17-gene signature based on four pathway databases.

Index	Name of pathway	value
1	BIOCARTA_FAS_PATHWAY	9.42-05
2	BIOCARTA_G_PATHWAY	2.23-04
3	BIOCARTA_G2_PATHWAY	5.99-05
4	BIOCARTA_HIVNEF_PATHWAY	3.55-04
5	BIOCARTA_TNFR_PATHWAY	2.04-04
6	BIOCARTA_TNFR1_PATHWAY	8.8-05
7	KEGG_CELL_CYCLE	1.61-03
8	KEGG_LEISHMANIA_INFECTION	5.17-04
9	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	1.79-03
10	KEGG_NON_HOMOLOGOUS_END_JOINING	1.7-05
11	KEGG_OXIDATIVE_PHOSPHORYLATION	1.77-03
12	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.9-03
13	KEGG_TGF_BETA_SIGNALING_PATHWAY	7.61-04
14	PID_AR_PATHWAY	3.93-04
15	PID_BARD_PATHWAY	3.36-07
16	PID_BARD1PATHWAY	3.36-07
17	PID_DNA_PK_PATHWAY	2.61-05
18	PID_DNAPK_PATHWAY	2.61-05
19	PID_PI3KCIAKTPATHWAY	1.29-04
20	PID_PIKCI_AKT_PATHWAY	1.29-04
21	REACTOME_DNA_REPAIR	1.16-03
22	REACTOME_DOUBLE_STRAND_BREAK_REPAIR	5.02-05
23	REACTOME_ION_CHANNEL_TRANSPORT	3.08-04
24	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	1.14-04